TrialInvestigational new drugs2014

Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.

Allyson J Ocean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.